Zobrazeno 1 - 10
of 224
pro vyhledávání: '"Intravenous bisphosphonates"'
Autor:
Azeez Farooki
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Hypercalcemia of malignancy (HCM) is a common clinical problem that is associated with considerable morbidity and negative effects on quality of life. Despite the availability of effective medical treatments for HCM, options are needed for cases that
Externí odkaz:
https://doaj.org/article/5de70f6c7bfd44a1af59430770b441c6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Laurent Arnaud, Jean Sibilia, Rose-Marie Javier, Luc Pijnenburg, Bénédicte Lebrun-Vignes, Joe-Elie Salem
Publikováno v:
European Journal of Endocrinology. 184:437-444
Objective Atrial fibrillation (AF) may be triggered by intravenous bisphosphonates (IVBPs) such as zoledronic acid or pamidronic acid. Our objective was to confirm the association between AF and IVBPs in a real-life large pharmacovigilance database.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 1, Pp 321-329 (2020)
Case Reports in Oncology
Case Reports in Oncology
Hypercalcemia is an ominous development in the course of malignancy associated with a mean survival of only several months. A majority of cases of hypercalcemia are related to humoral hypercalcemia of malignancy (HHM), where hypercalcemia is caused b
Publikováno v:
Journal of Osseointegration, Vol 4, Iss 1, Pp 15-20 (2012)
Background: Osteonecrosis of the jaw (ONJ) has been reported in the past few years in patients undergoing treatment with bisphosphonates (BP). Few published histological studies of ONJ can be found in the literature and no study has been reported on
Externí odkaz:
https://doaj.org/article/59002ef012cd478188da35fb19c5a8d4
Publikováno v:
Cancers. 13(13)
Simple Summary Around 30-60% of the patients with lung cancer develop bone metastases, which are associated with decreased survival, bone pain, and skeletal-related events such as need for radiation. Patients with an epidermal growth factor mutation
Publikováno v:
Medical alphabet. 3:34-36
This is a case study of patient with bisphosphonate associated osteonecrosis of the mandible after an extraction of teeth 4.6 and 4.7 complicated with pathological fracture while receiving intravenous bisphosphonates is discussed. The patients presen
Autor:
Soraya Sami, Kamel Bouzid
Publikováno v:
Batna Journal of Medical Sciences (BJMS). 6:18-21
Les métastases osseuses sont fréquentes dans le cancer du sein. Elles sont à l’origine d’une morbidité importante, entrainant des fractures, des douleurs osseuses, une compression médullaire ou une hypercalcémie. Les bisphosphonates intrave
Autor:
Sidhartha Tan, David Bryant, Susan Berman, Maheshwar Mahaseth, Salam Zeineddine, Sunil Jaiman, Edgar Hernandez-Andrade, Ali Alhousseini
Publikováno v:
Gynecologic and Obstetric Investigation. 84:204-208
Background: We discuss the ethical decision points in a case report that describes a novel COL1A1 mutation associated to Osteogenesis Imperfecta type II, but with a non-lethal outcome. Case: A 33-year-old female underwent a 21-week ultrasound that re